Induction of epithelial-mesenchymal transition with O-glycosylated oncofetal fibronectin

被引:30
|
作者
Ding, Yao
Gelfenbeyn, Kirill
Freire-de-Lima, Leonardo
Handa, Kazuko
Hakomori, Sen-itiroh [1 ]
机构
[1] Pacific NW Res Inst, Div Biomembrane Res, Seattle, WA 98122 USA
来源
FEBS LETTERS | 2012年 / 586卷 / 13期
关键词
Oncofetal FN; O-GalNAc; EMT; Non-small cell lung cancer; TGF beta 1; MONOCLONAL-ANTIBODY FDC-6; CELL MOTILITY; MALIGNANCY; REVERSION; INSIGHTS; HEALTH; FORM;
D O I
10.1016/j.febslet.2012.05.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial-mesenchymal transition (EMT) has been shown to play a key role in embryogenesis and cancer progression. We previously found that fibronectin (FN) carrying O-GalNAc at a specific site is selectively expressed in cancer and fetal cells/tissues, and termed oncofetal FN (onfFN). Here, we show that (i) a newly-established monoclonal antibody against FN lacking the O-GalNAc, termed normalFN (norFN), is useful for isolation of onfFN, (ii) onfFN, but not norFN, can induce EMT in human lung carcinoma cells, (iii) onfFN has a synergistic effect with transforming growth factor (TGF)beta 1 in EMT induction. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1813 / 1820
页数:8
相关论文
共 50 条
  • [21] Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages (Nov, 10.1007/s12026-022-09321-9, 2022)
    da Costa Santos, Marcos Andre Rodrigues
    dos Reis, Jhenifer Santos
    do Nascimento Santos, Carlos Antonio
    da Costa, Kelli Monteiro
    Barcelos, Pedro Marcal
    de Oliveira Francisco, Karen Queiroz
    Barbosa, Pedro Antonio Guimaraes Notaroberto
    da Silva, Emanuelle Damasceno Souza
    Freire-de-Lima, Celio Geraldo
    Morrot, Alexandre
    Decote-Ricardo, Debora
    Diniz-Lima, Israel
    Previato, Jose Osvaldo
    Mendonca-Previato, Lucia
    da Fonseca, Leonardo Marques
    Freire-de-Lima, Leonardo
    IMMUNOLOGIC RESEARCH, 2023, 71 (01) : 105 - 106
  • [22] Transcriptional controls for epithelial-mesenchymal and mesenchymal epithelial transition
    Hay, ED
    FASEB JOURNAL, 2004, 18 (05): : A762 - A762
  • [23] Epithelial-mesenchymal transition in cancer
    Moustakas, Aristidis
    Garcia de Herreros, Antonio
    MOLECULAR ONCOLOGY, 2017, 11 (07): : 715 - 717
  • [24] A milestone in epithelial-mesenchymal transition
    Sun, Yutong
    Ma, Li
    NATURE CELL BIOLOGY, 2024, 26 (01) : 29 - 30
  • [25] Epithelial-mesenchymal transition in the liver
    Firrincieli, D.
    Boissan, M.
    Chignard, N.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (10): : 523 - 528
  • [26] Epithelial-mesenchymal transition in the skin
    Nakamura, Motonobu
    Tokura, Yoshiki
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 61 (01) : 7 - 13
  • [27] Targeting epithelial-mesenchymal transition
    Luft, Friedrich C.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (07): : 703 - 705
  • [28] Cortactin in Epithelial-Mesenchymal Transition
    Ji, Rong
    Zhu, Xiao-Juan
    Wang, Zhi-Rong
    Huang, Li-Qiang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [29] The basics of epithelial-mesenchymal transition
    Kalluri, Raghu
    Weinberg, Robert A.
    JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06): : 1420 - 1428
  • [30] Epithelial-Mesenchymal Transition (EMT)
    Manfioletti, Guidalberto
    Fedele, Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)